The Scientific
Alliance.

All French liver transplantation centers.

Beaujon University Hospital

Pr Weiss
Dr Devauchelle
Dr Thibault

Pr Weiss Emmanuel

Department of Anesthesiology and Critical Care Medicine

LINKEDIN

Choose your center

Born from two national collaborative projects.

01 The national survey project

The national survey project

A national benchmark of French perioperative practices in liver transplantation revealing significant variations due to the lack of scientific data and unmet needs.

Read about the project
2 years project duration
2025 published
02 HEMOTRANSPLANT Study

HEMOTRANSPLANT Study

HEMOTRANSPLANT is a nationwide multicenter study of 1,200 liver transplant patients designed to identify predictors of transfusion needs, enabling improved hemorrhage management, reduced costs, and standardized clinical practice.

Read about the project
2 years project duration
Q3 2026 last patient enrolled
€412K funds raised
SFAR & LFB sponsors

Now building together

The French liver
transplantation database project

with  pre-operative  Data

Strong Data.

Cardiovascular & Hemodynamics
  • Q01 Preoperative cardiovascular assessment
  • Q02 Incidence and outcomes of cardiovascular complications
  • Q03 Perioperative hemodynamic optimization: vasopressors, fluids & monitoring
Hemostasis & Transfusion
  • Q01 Hemostasis point-of-care testing
  • Q02 Hemostatic therapies: which ones, when, and for whom?
  • Q03 Blood cell salvage strategies
  • Q04 Bleeding vs thrombosis balance
Immunity, Immunosuppression & Infectious Diseases
  • Q01 Personalized infection prevention: vaccination, viral, fungal, and bacterial prophylaxis strategies
  • Q02 Tailored immunosuppressive strategies
  • Q03 Immune monitoring
  • Q04 Facing multidrug-resistant organisms
Acute Liver Failure & ACLF
  • Q01 Incidence and perioperative outcomes of ALF and ACLF
  • Q02 Therapeutic plasma exchange as a bridge to transplant
  • Q03 Innovative immunomodulatory pharmaceutical and extracorporeal strategies
  • Q04 Predictors of transplant futility
Nephrology
  • Q01 Liver-kidney crosstalk before, during, and after LT
  • Q02 Assessing the impact of intraoperative kidney replacement therapy in patients with preoperative AKI
  • Q03 Minimizing kidney toxicity of immunosuppressive therapy
  • Q04 Long-term kidney outcomes after liver transplantation
Nutrition, Rehabilitation & Quality of Life
  • Q01 Prehabilitation in liver transplantation candidates
  • Q02 Fast track pathways after the surgery
  • Q03 Patient-reported outcome measures and patient-reported experience measures
  • Q04 Quality of life and associated risk factors
  • Q05 Post-intensive care syndrome and post-traumatic stress disorders: incidence and outcomes
Oncology
  • Q01 Impact of immunotherapy and new locoregional therapies on perioperative outcomes of patients with HCC
  • Q02 New indications of LT for primary and secondary cancer: window of opportunity and long-term outcomes
  • Q03 Perioperative immunosuppressive strategies: balancing graft rejection vs oncological recurrence
Graft Allocation & Function
  • Q01 Predictive tools and machine-learning algorithms to anticipate graft function
  • Q02 Donor-recipient matching
  • Q03 Large-scale assessment of machine perfusion impact
Powered by
Institutions
Le Foie SFAR AP-HP
Powered by
Patients
Transhépate
Powered by
You?

Want to support the project ?
Contact us  and join the adventure.

Paris skyline
BiLiver
Legal Notice Privacy Policy Committee Representatives
© 2026 BiLiver — SFAR